首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >Study of the interaction of broad-spectrum antimicrobial drug sitafloxacin with human serum albumin using spectroscopic methods, molecular docking, and molecular dynamics simulation
【24h】

Study of the interaction of broad-spectrum antimicrobial drug sitafloxacin with human serum albumin using spectroscopic methods, molecular docking, and molecular dynamics simulation

机译:使用光谱法,分子对接和分子动力学模拟对人血清白蛋白的广谱抗菌药物Sitafloxacin与人血清白蛋白相互作用的研究

获取原文
获取原文并翻译 | 示例
           

摘要

Sitafloxacin (STFX) is a new generation of broad-spectrum oral fluoroquinolones. STFX has significantly enhanced antibacterial activity than most similar drugs. Clinically, this drug is mainly used to treat respiratory and urinary tract infections and other serious bacterial infections. In this study, the interaction between sitafloxacin and human serum albumin (HSA) was investigated by spectroscopic methods and molecular simulations. Fluorescence quenching experiments showed that the interaction mechanism between STFX and HSA was static quenching, which was confirmed by time-resolved fluorescence. Thermodynamic parameters and docking results indicated that hydrophobic and electrostatic forces played a key role in this mechanism. Probe experiments and molecular docking results indicated that the major binding of STFX was at site I. 3D fluorescence showed that the insertion of STFX had minimal impact on the microenvironment. Analysis of the protein secondary structure showed that the insertion of STFX had little effect on the secondary structure of the protein. Hydrophobicity experiments showed the slight decrease in the overall hydrophobicity index of the system. Molecular dynamics simulations further validated the stability of the HSA-STFX complex. This study are useful for further drug development, in vivo toxicity studies, and can provide guidance for the clinical application of STFX to study its pharmacokinetic properties.
机译:Sitafloxacin(STFX)是一代新一代的广谱口服氟喹诺酮。 STFX显着增强了比大多数相似的药物的抗菌活性。临床上,这种药物主要用于治疗呼吸系统和泌尿道感染和其他严重的细菌感染。在该研究中,通过光谱方法和分子模拟研究了SitaFloxacin和人血清白蛋白(HSA)之间的相互作用。荧光猝灭实验表明,STFX和HSA之间的相互作用机理是静态猝灭,其通过时间分辨荧光证实。热力学参数和对接结果表明,疏水性和静电力在该机制中发挥了关键作用。探针实验和分子对接结果表明,STFX的主要结合在现场I. 3D荧光表明,STFX的插入对微环境影响最小。蛋白质二级结构的分析表明,STFX的插入对蛋白质的二级结构几乎没有影响。疏水性实验表明系统的整体疏水性指数略微降低。分子动力学模拟进一步验证了HSA-STFX复合物的稳定性。本研究可用于进一步的药物开发,体内毒性研究,可以为STFX的临床应用提供指导,研究其药代动力学性质。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号